chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient's mother reports that by 7 PM last night that child was not "functioning" well and was moving slowly. He did not have any symptoms of anaphalaxis such as swelling, difficulty breathing, hives and he did not report any fever or pain at injection site.  Mother did speak to child's physician who encouraged her to call health department. I advised that if child is still feeling sleepy and having stomach pain that she needs to seek medical care. Child currently at high school and texting mom that he feels like he is going to pass out and feels tired.
Information has been received from a physician concerning a 9-year-old child who was vaccinated on an unspecified date with varicella virus vaccine live (Oka/Merck). Concomitant vaccination included influenza virus 3v reassortant vaccine live intranasal (cold adapted Ann Arbor master strain) (FLU MIST) (MedImmune). Subsequently the patient experienced a possible anaphylactic reaction which included wheezing, shortness of breath, facial edema and facial mottling. The patient was stabilized and transported to the nearest hospital. No other information was available. This event did not occur at the reporting physicians office. This is one of several reports from the same reporter. Additional information has been requested.
A report has been received from a health professional concerning an 11 year old, female patient. The patient's medical history and concomitant medications were not reported. On 28-Sep-2012, received nasal FLUMIST after a power outage on 25-Sep-12 when storage unit reached 50 degrees F. FLUMIST was administered to the patient after six hours after the cut-off time and experienced cold chain break. The patient recovered from the events. The report was considered to be non-serious by reporter. Summary of follow-up information received by AstraZeneca/MedImmune from HCP on 23-Oct-2012: new adverse event, patient's sex, age, reporter's phone number, duration of the events added, outcome changed to recovered.
Left uppper arm swelling, red 5 inches in diameter, hot, & hard & painful.  Neosporin, & ice packs, & Tylenol. Day 4 reduced in size to 3 inches Day 6 gone.
It started with a pain in my wrist. Then it started to move up my arm, into my shoulder. It felt like a tingling, burning sensation. This is my right arm, not the left arm where I received the second dose. I was having trouble sleeping at night and I was having a stabbing sensation in my ear. I had a toothache in my mouth on the right side. They gave me amoxicillin. The tooth pain went away, and my ear did to a few days later. The pain in my arm did not go away. I went to the ER and they told me I might have carpal tunnel syndrome. They gave me steroids.  I also have a tingling sensation in my fingers. My normal doctor told me I had the symptoms of a pinched nerve, but they didn't think it was a pinched nerve, but nerve damage. I went to a neurologist. I was having so much pain in my arm that I was having trouble sleeping. The neurologist said they would have to run tests.
- Fever 102 and chills approximately 14 hours after injection; lasting 8 hours  -Fever dropping to 100, muscle aches, headache approximately 22 hours after injection; lasting approximately 24 additional hours
a little girl that has bad reaction to shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (a little girl that has bad reaction to shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Previously administered products included for Drug use for unknown indication: A and B shots (she has done A and B shots and both wipe her out.). Past adverse reactions to the above products included Adverse event with A and B shots. Concurrent medical conditions included Drug allergy.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (a little girl that has bad reaction to shot). At the time of the report, VACCINATION COMPLICATION (a little girl that has bad reaction to shot) outcome was unknown.            Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.   This case was linked to MOD-2021-409294, MOD-2021-408510 (Patient Link).
Patient was vaccinated with Pfizer (grey cap) Lot: FJ5683, at 1600 on 2/11/2022. This was a booster dose of Pfizer (the client had also received Pfizer for initial vaccine series). At 1605 client reported headache and nausea, which client reported "this happened with each of my other doses too and with blood donation which is why I can't donate anymore". No visible pallor, shakiness, observed. 1611 initially unable to auscultate BP with multiple attempts, SPO2 100% on RA and HR 88. Client declined to lay down stating "laying down makes the pain much worse". Offered apple juice and cold pack placed on back of neck. Client C/O "just a little bit of lightheadedness" at 1616. 1620 able to verify BP 118/72, HR 86, SPO2 100%. Patient allowed to sit, rest, and recuperate. Client did have history of severe allergy and was to be monitored for 30 minutes. At 1630 client still C/O headache and nausea, husband able to verify that appearance was consistent with baseline and RN determined no signs or symptoms of allergic reaction. Education was provided to couple regarding when to seek medical attention and additional symptoms of allergic reaction. Verbal confirmation from client and spouse that they understood instructions. 1636 improved auscultation of BP 116/74, HR 84, SPO2 99%. Client and spouse felt comfortable and departing unassisted from clinic at 1638.
At approximately 3:30, developed significant headache. Later that day, severe fever and chills began with significant uncontrollable shivering. Fever was unrelieved by around the clock Tylenol. Symptoms lasted approximately 36 hours from time of injection.
Flu like symptoms (Symptoms lasted for 36 hours); Chills; Slight fever (99 degrees); Headache; Pain at the injection site lasted over a week; Red rash at injection site lasted three weeks; Red rash at injection site lasted three weeks; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 26Mar2021 at 16:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, peptic ulcer, bipolar disorder, sleep apnea and endometriosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN) supplements for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 04Mar2021 at 12:00 as a single dose for COVID-19 immunisation. On 26Mar2021 at 20:00, the patient experienced flu like symptoms, chills, slight fever of 99 degrees (unspecified units), headache, pain at the injection site lasted over a week and red rash at injection site that lasted three weeks. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, chills, slight fever (99 degrees), headache was recovered on 28Mar2021 at 08:00, after the duration of 36 hours. The clinical outcome of the events pain at the injection site was recovered on an unknown date in Apr2021 after the duration of over a week; while that of the event red rash at injection site was recovered on an unknown date in Apr2021, after the duration of 3 weeks.   No follow-up attempts are needed. No further information is expected.
center of left upper arm needle pain (shock feeling), numbness shooting down arm to fingers. loss of squeeze motion.  these effects are intermittent. went to chiropractor for adjustment before i found out others were having similar problems.
The same day the arm started to hurt and felt tight, thing that I thought it was normal until next day that the pain got worse and by the evening my arm was swollen all the way to the elbow. The pain started to move close to the neck and down the whole arm. I went to a clinic to avoid an emergency care but besides a reaction they could not determine exactly what was going on and was sent to another walk-in clinic. Prednisone pills were prescribed.
After few minutes of MMR + Varicella vaccines administration child's right thigh became red and indurated.
101+ fever, chills, night sweats, headache, body aches. Onset approximately 16 hours s/p second moderna dose and have persisted for last 3-4 hours.
Received flu vaccine requisite to his service as a volunteer at hospital ER.  Previously healthy. Within 1 day of vaccination began complaining of flu-like symptoms. Developed pneumonia, pleural effusion, SOB.  Was hospitalized, then released to home where he expired.
Vaccine painful, unable to move arm, shooting pains, tingling, numbness in arm. Pt went to urgent care, then ER. Given X-rays, sling, and pain medication.
Pt ran fever but mom stated that thermometer was broken during the night. States was delusional and trembling.
Reactions - a "mini tour" of covid; Reactions - a "mini tour" of covid; Exhausted for a couple of weeks afterward each shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Apr2021 16:00 (Lot number: Er2613) at the age of 49 years as dose 2, single and administered in arm left, administration date 18Mar2021 21:00 (Lot number: Er2613) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: Covid prior vaccination: Yes. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Reactions - a "mini tour" of covid"; FATIGUE (non-serious), outcome "unknown", described as "Exhausted for a couple of weeks afterward each shot". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, suspected covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101777539 same reporter/ patient/ drug, different event/ dose
This case was reported by a healthcare professional and described the occurrence of arm numbness in a 30-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date the subject received 1st dose of FLULAVAL (.5 ml, unknown, left arm). At an unspecified time after vaccination with FLULAVAL, the subject experienced numbness down the arm from injection site. At the time of reporting the outcome of the arm numbness was unspecified. This is the second of two cases by the nurse, see case A0884295A. Follow-up information received via the reporting nurse indicated that this patient was a temporary employee and specific medical information requested is not available. Follow-up information was received on 25 October 2010. It was reported that the patient was 37 years old at the time of events. He received a dose of FLULAVAL on 29 September 2010 and an unknown amount of time following and on the same day, the patient experienced a vaccine reaction. Arm numbness was reported. The events were considered to be resolved on 29 September 2010. Numbness occurred for less than one hour. It was noted that the patient had a fear of needles and tensed his arm muscle during FLULAVAL administration which may have been associated with the reported events.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 01-APR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 33 degrees Fahrenheit (0.555555556 degrees Celsius) (lowest recorded temperature) for 368 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
L arm pain, swelling redness, fever, night sweats, diarrhea, fatigue for 3 days cough congestion
Moderna 4/18/21, 5/16/21, 11/1/21. Positive on 6/30/22
Patient is fully vaccinated.  COVID-19 positive on 12/25/2021 on admission to hospital. 93-year-old male with reported cough and shortness of breath. The patient denied any chest pain, abdominal pain, nausea, vomiting or diarrhea. Admission diagnosis: CHF, SOB, elevated troponin and COVID-19. CT PE: Patchy ground glass airspace opacities, peripherally throughout the lungs bilaterally. Findings concerning for underlying atypical viral pneumonitis. No evidence of pulmonary embolism. Treatment: Oxygen, Decadron and Remdesivir. Positive hematuria; no anticoagulation therapy.
Received his 4th anthrax vaccine (FAV163, in left deltoid, also received MENACTRA in left arm) on 3/27/08.  In clinic on 3/31 with complaints of tender sub-q nodule (about 2 cm), slight erythema surrounding vaccination site (<1.5), and mild axillary point tenderness, but no enlarged lymph nodes.  No systemic symptoms.  When I spoke to him briefly on 4/8/08, he said the vaccine site symptoms were decreasing.  Symptoms: Edema at injection site 30-50mm, Erythema, Nodule, subcutaneous, Tenderness.
About 1 minute after receiving vaccine, pt fainted while on the way to recovery area. Pt was standing in entryway when he started to fall down but was caught on the way down by a nurse. While on the floor the pt was asked his name and responded with correct answer, EMS was called and then pt was placed in wheelchair and transferred to cot after. the BP and pulse was taken (63/46, pulse 51) Glucose gel was provided orally. EMS arrived shortly after BP was take but pt refused stating that he was feeling better and he waited out the remainder of his recovery time laying in cot with no other incidents.
Approximately three days post vaccine I began having elevated, racing heart rate and chest pains/muscle/joint pains. This got to the point of being so uncomfortable I scheduled with my PCP and I was diagnosed with Costochondritis (cartilage inflammation in the chest wall/costal joints) on 1/15/21. I have had continued problems with muscle pain in my chest, back, neck and other areas, as well as joint pain, especially in my hands and feet. This has now been going on 3 months.
The evening after the vaccine Developed severe abdominal pain and joint pains  This lasted about a week  Also developed mild rash and  itch the day after the vaccine  Had extreme fatigue for about a week  The second morning developed what appeared to be swollen blood vessels in both forearms This lasted several hours and went away   Went To dr  and received fluids and vitamin iv
COULD NOT SLEEP ON EITHER SIDE; BOTH ARMS SORE; This spontaneous report received from a consumer via a company representative concerned a 40 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced could not sleep on either side, and both arms sore. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the could not sleep on either side and both arms sore was not reported. This report was non-serious. This case, from the same reporter is linked to 20220113961, 20220114079 and 20220114182.
No adverse event patient had been PCR positive in January and has remained so since that time.  Testing was completed erroneously preoperatively.
Mild pain in shoulder where shot was administered beginning 10/18/12, followed by the appearance 10/22/12 of bruises at the shot site and 2 additional locations a few inches below the shot site. Each bruise has underlying mild pain.
pt recvd DTP/HIB 18NOV; exp fever (102 highest), cranky, legs sl swollen 15 hrs p/shots devel rash on head/hair area; To MD on 22NOV dx ear infect & put on Ceclor; MD felt rash from DTP or viral; parents felt rash was allergy to milk;
4 days after the vaccine I developed ringing in both ears.  This has persisted non stop for every since.
Starting 10/01/2022, I developed severe coughing to the point where I was having a hard time catching my breath. I tested myself for COVID at home and it was positive. The coughing was severe that weekend and on monday, 10/03/2022, I had a telehealth visit, where I was prescribed Paxlovid and an inhaler and something for the headaches. I started the Paxlovid the same day and it worked wonders. After 5 days, I felt very close to normal just a little tired.   I had just gotten back from a trip at the end of September. (returned 09/21/2022). We stayed for 4 days upon arrival before heading home.
PATIENT BEGAN TO FEEL DIZZY AND UNSTEADY ON FEET AT APPROXIMATELY 10PM DAY AFTER VACCINE.
Patient started having shoulder pain the next day, she tried home remedies, visited her regular doctor who sent her to the orthopedic specialist. Currently patient is on physical therapy and non steroidal anti-inflammatory medications.
Patient reports roughly a week later tingling on his right shoulder, developed rash, diagnosed with shingles on 9/29/2022
Face swelled two day later possibly due to dermal filler that was injected in late 2019. Lymph nodes also swelled in R under arm are at the same time of face swelling.
PATIENT RETURNED TO CLINIC FOR FOLLOW-UP TB READING. MOM STATED PATIENT HAD FEVER AND VOMITING FOR 2 DAYS ALONG WITH SWELLING TO LEFT ARM. RX - ACETAMINOPHEN FOR FEVER AND PAIN
Left upper arm is sore 6/10 has muscle knot in area where shot was given.
MYOCARDITIS resulting in complete heart block. Continuous defibrillator machines require from approx. 60 minutes.  Emergency external pacemaker installation required, followed by permanent pacemaker the next day.
Started off w/upset stomach, lethargy and headache. This progressed to localized bruising at the site. On Monday there was a large hive at the site and some itching. On Tuesday, 8/16, she complained of severe itching all over, "feeling on fire"!
Lt deltoid muscle on 2nd and 3rd day after DTAP became red and swollen area was approximately 2" around. Child seems to be doing well today on 3/23/06.
Pt developed lump on rt deltoid that is red, warm to the touch, sore, burning sensation, itchy.
Body aches, slight fever and chills, general malaise beginning about 14 hours after 2nd dose was administered. Aleve taken 4 hours after onset of side effects. Side effects seem to be diminishing 32 hours after 2nd dose.
NOSEBLEED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included vaping, and concurrent conditions included alcohol user, and cigarette smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit use and had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 18:20 on right deltoid for prophylactic vaccination. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate for drug used for unknown indication. On 30-MAR-2021 23:00, the subject experienced nosebleed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed on 30-MAR-2021 23:10. This report was non-serious.
Patient reports that immediately after injection her right eye "was twitching." She went home and within 2 hours both eyes were "severely twitching" the injection site was red, hot and swollen and very painful. She states symptoms lasted for about 3 days. She was in clinic today (11/10/16) and said she can still feel bump at injection site.
Dialysis; While in the procedure he started to feel unwell; Headache; felt hot in the back of the head; Tiredness; he felt dizzy 4 times/Dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Jul2023 at 09:00 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer, 1 year ago he had received another dose of the vaccine.), for COVID-19 immunisation. The following information was reported: DIALYSIS (medically significant) with onset 12Jul2023, outcome "unknown"; HEADACHE (non-serious) with onset 12Jul2023, outcome "recovering"; FATIGUE (non-serious) with onset 12Jul2023, outcome "recovering", described as "Tiredness"; MALAISE (medically significant) with onset 12Jul2023, outcome "recovering", described as "While in the procedure he started to feel unwell"; FEELING HOT (non-serious) with onset 12Jul2023, outcome "recovering", described as "felt hot in the back of the head"; DIZZINESS (non-serious) with onset 12Jul2023, outcome "recovering", described as "he felt dizzy 4 times/Dizziness". Therapeutic measures were taken as a result of malaise, headache, feeling hot, fatigue, dizziness. Clinical course: Caller explained that yesterday (11Jul2023) around 9 AM, he received the booster dose of the Pfizer-BioNTech COVID-19 vaccine. He mentioned that 1 year ago he had received another dose of the vaccine. Today (12Jul2023) around 8:30 AM he underwent dialysis. While in the procedure he started to feel unwell; he felt dizzy 4 times. About every half hour he felt dizzy again, and this was repeated 4 times. He described that he was lying down and that's why he couldn't fall, but he felt like he was going to faint. He had a headache and felt "hot" in the back of the head. He was given Tylenol at the site. All of these symptoms occurred about 24 hours after vaccination. He explained that at the time of the call he had no longer had those symptoms and that he was feeling better. He wanted to know how to treat his symptoms if it happened again.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.